Douglas Marvel
Impact in
- Immunology top 2%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Phagocytosis and Immune Regulation
- Immune Response and Inflammation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Papers in
-
- Immune cells in cancer 3
- Immunotherapy and Immune Responses 2
- T-cell and B-cell Immunology 2
- Oncology 2
- Chemokine receptors and signaling 2
- Co-authors
- Dmitry I. Gabrilovich (1 shared paper)Olivera J. Finn (2 shared papers)Adam M. Farkas (1 shared paper)Kathleen T. Montone (1 shared paper)Alexander G. Chiu (1 shared paper)Benjamin Saul Bleier (1 shared paper)Erica R. Thaler (1 shared paper)Duane A. Sewell (1 shared paper)
- Journals
- Cancer Cell (2 papers)Frontiers in Immunology (1 paper)The Journal of Immunology (1 paper)Journal of Clinical Investigation (1 paper)Archives of Otolaryngology - Head and Neck Surgery (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Douglas Marvel
6 papers receiving 1.5k citations
Douglas Marvel's Hit Papers
Peers
Comparison fields: 5 of 69
- Immunology 1.1k
- Oncology 723
- Cancer Research 115
- Neurology 53
- Biological Psychiatry 13
Countries citing papers authored by Douglas Marvel
This map shows the geographic impact of Douglas Marvel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Marvel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Marvel more than expected).
Fields of papers citing papers by Douglas Marvel
This network shows the impact of papers produced by Douglas Marvel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Marvel. The network helps show where Douglas Marvel may publish in the future.
Co-authors
The 8 scholars most cited alongside Douglas Marvel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected Hit paper breakdown → | 2015 | 919 |
| 2 | Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors Hit paper breakdown → | 2017 | 545 |
| 3 | 2022 | 43 | |
| 4 | 2014 | 5 | |
| 5 | 2013 | 5 | |
| 6 | 2008 | 2 |
About Douglas Marvel
Douglas Marvel is a scholar working on Immunology, Oncology, Pathology and Forensic Medicine, Molecular Biology and Epidemiology, having authored 6 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), vaccines and immunoinformatics approaches (2 papers), Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers), Chemokine receptors and signaling (2 papers), Head and Neck Surgical Oncology (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Cervical Cancer and HPV Research (1 paper). The work is most often cited by research in Immunology (1.1k citations), Oncology (723 citations), Cancer Research (115 citations), Neurology (53 citations) and Biological Psychiatry (13 citations). Douglas Marvel has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Dmitry I. Gabrilovich, Olivera J. Finn, Adam M. Farkas, Kathleen T. Montone, Alexander G. Chiu, Benjamin Saul Bleier, Erica R. Thaler and Duane A. Sewell. Their work appears in journals such as Cancer Cell, Frontiers in Immunology, The Journal of Immunology, Journal of Clinical Investigation and Archives of Otolaryngology - Head and Neck Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.